Spontaneous Subcapsular Hematoma from Rivaroxaban
Open Access
- 21 December 2018
- journal article
- Published by Peertechz Publications Private Limited in Archives of Hematology Case Reports and Reviews
- Vol. 3 (1), 004-006
- https://doi.org/10.17352/ahcrr.000012
Abstract
Rivaroxaban was approved for stroke prevention for non-valvular atrial fibrillation in 2011, with added advantage of decreased risk of bleeding in comparison to coumadin, made it a good alternative for coumadin.Keywords
This publication has 11 references indexed in Scilit:
- Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trialHeart Rhythm, 2017
- Spontaneous Subcapsular Renal Hematoma: Strange Case in an Anticoagulated Patient with HWMH after Aortic and Iliac Endovascular Stenting ProcedureCase Reports in Urology, 2016
- Anticoagulation in chronic kidney disease patients--the practical aspectsClinical Kidney Journal, 2014
- A Case of Rivaroxaban Associated Intracranial HemorrhageWestern Journal of Emergency Medicine, 2014
- Wunderlich SyndromeJournal of Computer Assisted Tomography, 2011
- Oral Rivaroxaban for Symptomatic Venous ThromboembolismThe New England Journal of Medicine, 2010
- Spontaneous Renal Subcapsular Hematomain an Anticoagulated PatientClinical and Applied Thrombosis/hemostasis, 2006
- Massive Intraperitoneal Hemorrhage Associated with Renal PathologyJournal of Urology, 1994
- Spontaneous subcapsular and perirenal hematomas.Radiology, 1989
- Spontaneous Subcapsular Renal Hematoma: Diagnosis and ManagementJournal of Urology, 1988